Citation: Yunyan Li, Zimin Cai, Zhicheng Wang, Sifeng Zhu, Wendian Liu, Cheng Wang. Construction of biomimetic hybrid nanovesicles based on M1 macrophage-derived exosomes for therapy of cancer[J]. Chinese Chemical Letters, ;2025, 36(4): 109942. doi: 10.1016/j.cclet.2024.109942 shu

Construction of biomimetic hybrid nanovesicles based on M1 macrophage-derived exosomes for therapy of cancer

Yunyan Li ^a ,
Zimin Cai ^a ,
Zhicheng Wang ^a ,
Sifeng Zhu ^a ,
Wendian Liu ^a ,
Cheng Wang ^{a, b, *,}

a.
Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China
b.
Laboratory for Marine Drugs and Bioproducts, Pilot National Laboratory for Marine Science and Technology, Qingdao 266237, China

cheng13980029671@163.com

Received Date: 20 February 2024
Revised Date: 24 April 2024
Accepted Date: 28 April 2024
Available Online: 29 April 2024

Figures(5)

Established evidence has unveiled two strategies for treating cancer: depleting tumor-associated macrophages (TAMs) and reprogramming M2-like TAMs into an antitumor M1 phenotype. Here, we designed novel pH-sensitive biomimetic hybrid nanovesicles (EDHPA) loaded with doxorubicin (DOX). DOX@EDHPA can specifically target TAMs by activating macrophage-derived exosomes (M1-Exos) and anisamide (AA) as cancer-specific targeting ligands. In vitro and in vivo studies demonstrated that DOX@EDHPA could efficiently be delivered to the tumor site and taken up by cells. Meanwhile, it synergistically enhanced immunogenic cell death (ICD) and induced a subsequent antigen-specific T cell immune response. The tumor inhibitory rate of the DOX@EDHPA group was 1.42 times that of the free DOX group. Further analysis showed that the excellent antitumor effects of DOX@EDHPA should ascribe to the homing effect of M1-Exos on macrophages and the repolarization to antitumor M1 TAMs, which induced the elevated secretion of pro-inflammatory factors. Therefore, the hybrid EDHPA targeting TAMs to reshape the tumor microenvironment constituted a novel immunochemotherapy strategy to inhibit tumor growth.
- Tumor-associated macrophages,
- M1-Exos,
- Hybrid nanovesicles,
- Immunogenic cell death,
- Immunochemotherapy
1. [1]
  S. Shen, H.J. Li, K.G. Chen, et al., Nano Lett. 17 (2017) 3822–3829. doi: 10.1021/acs.nanolett.7b01193
2. [2]
  Y. Chen, R. Xia, Y. Huang, et al., Nat. Commun. 7 (2016) 13443. doi: 10.1038/ncomms13443
3. [3]
  X. Duan, C. Chan, W. Han, et al., Nat. Commun. 10 (2019) 1899. doi: 10.1038/s41467-019-09221-x
4. [4]
  A.M. Cook, W.J. Lesterhuis, A.K. Nowak, R.A. Lake, Curr. Opin. Immunol. 39 (2016) 23–29. doi: 10.1016/j.coi.2015.12.003
5. [5]
  T.A.P. Driedonks, S.G. van der Grein, Y. Ariyurek, et al., Cell. Mol. Life Sci. 75 (2018) 3857–3875. doi: 10.1007/s00018-018-2842-8
6. [6]
  S. Quader, K. Kataoka, Mol. Ther. 25 (2017) 1501–1513. doi: 10.1016/j.ymthe.2017.04.026
7. [7]
  S. Kourembanas, Annu. Rev. Physiol. 77 (2015) 13–27. doi: 10.1146/annurev-physiol-021014-071641
8. [8]
  Y. Wu, Z. Zhang, Y. Wei, Z. Qian, X. Wei, Chin. Chem. Lett. 34 (2023) 108098. doi: 10.1016/j.cclet.2022.108098
9. [9]
  N.L. Syn, L.Z. Wang, E.K.H. Chow, C.T. Lim, B.C. Goh, Trends Biotechnol. 35 (2017) 665–676. doi: 10.1016/j.tibtech.2017.03.004
10. [10]
  J. Dai, Y. Su, S. Zhong, et al., Signal Transduct. Target Ther. 5 (2020) 145. doi: 10.1038/s41392-020-00261-0
11. [11]
  Y. Zhang, Y. Liu, H. Liu, W.H. Tang, Cell Biosci. 9 (2019) 19. doi: 10.1186/s13578-019-0282-2
12. [12]
  A. Mukherjee, B. Bisht, S. Dutta, M.K. Paul, Acta Pharmacol. Sin. 43 (2022) 2759–2776. doi: 10.1038/s41401-022-00902-w
13. [13]
  H. Zhang, K. Tang, Y. Zhang, et al., Cancer Immunol. Res. 3 (2015) 196–205. doi: 10.1158/2326-6066.CIR-14-0177
14. [14]
  F.O. Martinez, A. Sica, A. Mantovani, M. Locati, Front. Biosci. 13 (2008) 453–461. doi: 10.2741/2692
15. [15]
  M. Yang, J.Q. Chen, F. Su, et al., Mol. Cancer 10 (2011) 117.
16. [16]
  C.B. Anders, T.M.W. Lawton, H.L. Smith, et al., J. Leukoc. Biol. 111 (2022) 667–693. doi: 10.1002/jlb.6a1120-744r
17. [17]
  T. Yin, Q. Fan, F. Hu, et al., Nano Lett. 22 (2022) 6606–6614. doi: 10.1021/acs.nanolett.2c01863
18. [18]
  Y.W. Choo, M. Kang, H.Y. Kim, et al., ACS Nano 12 (2018) 8977–8993. doi: 10.1021/acsnano.8b02446
19. [19]
  J.A. Reales-Calderon, C. Vaz, L. Monteoliva, G. Molero, C. Gil, J. Proteome Res. 16 (2017) 87–105. doi: 10.1021/acs.jproteome.6b00605
20. [20]
  L. Cheng, X. Zhang, J. Tang, Q. Lv, J. Liu, Biomaterials 275 (2021) 120964. doi: 10.1016/j.biomaterials.2021.120964
21. [21]
  R. Majeti, M.P. Chao, A.A. Alizadeh, et al., Cell 138 (2009) 286–299. doi: 10.1016/j.cell.2009.05.045
22. [22]
  A. Macedo-Pereira, C. Martins, J. Lima, B. Sarmento, J. Control. Release 358 (2023) 98–115.
23. [23]
  Q. Lv, L. Cheng, Y. Lu, et al., Adv. Sci. 7 (2020) 2000515. doi: 10.1002/advs.202000515
24. [24]
  M.S. Kim, M.J. Haney, Y. Zhao, et al., Nanomedicine 14 (2018) 195–204.
25. [25]
  K.M. Kanninen, N. Bister, J. Koistinaho, T. Malm, Biochim. Biophys. Acta 1862 (2016) 403–410.
26. [26]
  S.M. van Dommelen, P. Vader, S. Lakhal, et al., J. Control. Release 161 (2012) 635–644.
27. [27]
  J. Gao, S. Wang, Z. Wang, Biomaterials 135 (2017) 62–73.
28. [28]
  M. Piffoux, A.K.A. Silva, C. Wilhelm, F. Gazeau, D. Tareste, ACS Nano 12 (2018) 6830–6842. doi: 10.1021/acsnano.8b02053
29. [29]
  W.J. Goh, S. Zou, C.K. Lee, et al., Biomacromolecules 19 (2018) 22–30. doi: 10.1021/acs.biomac.7b01176
30. [30]
  Y. Lin, J. Wu, W. Gu, et al., Adv. Sci. 5 (2018) 1700611.
31. [31]
  M. Hu, J. Zhang, L. Kong, et al., ACS Nano 15 (2021) 3123–3138. doi: 10.1021/acsnano.0c09681
32. [32]
  A. Dasargyri, C.D. Kümin, J.C. Leroux, Adv. Mater. 29 (2016) 1603451.
33. [33]
  J. Cho, Y.S. Lee, S.H. Kim, J.K. Ko, C.W. Kim, Cancer Lett. 275 (2009) 256–265. doi: 10.3346/jkms.2009.24.2.256
34. [34]
  S. Rayamajhi, T.D.T. Nguyen, R. Marasini, S. Aryal, Acta Biomater. 94 (2019) 482–494.
35. [35]
  D. Kalyane, N. Raval, R. Maheshwari, et al., Mater. Sci. Eng. C Mater. Biol. Appl. 98 (2019) 1252–1276.
1. [1]
  Kun-Heng Li , Hong-Yang Zhao , Dan-Dan Wang , Ming-Hui Qi , Zi-Jian Xu , Jia-Mi Li , Zhi-Li Zhang , Shi-Wen Huang . Mitochondria-targeted nano-AIEgens as a powerful inducer for evoking immunogenic cell death. Chinese Chemical Letters, 2024, 35(5): 108882-. doi: 10.1016/j.cclet.2023.108882
2. [2]
  Xinyue Lan , Junguang Liang , Churan Wen , Xiaolong Quan , Huimin Lin , Qinqin Xu , Peixian Chen , Guangyu Yao , Dan Zhou , Meng Yu . Photo-manipulated polyunsaturated fatty acid-doped liposomal hydrogel for flexible photoimmunotherapy. Chinese Chemical Letters, 2024, 35(4): 108616-. doi: 10.1016/j.cclet.2023.108616
3. [3]
  Liangliang Jia , Ye Hong , Xinyu He , Ying Zhou , Liujiao Ren , Hongjun Du , Bin Zhao , Bin Qin , Zhe Yang , Di Gao . Fighting hypoxia to improve photodynamic therapy-driven immunotherapy: Alleviating, exploiting and disregarding. Chinese Chemical Letters, 2025, 36(2): 109957-. doi: 10.1016/j.cclet.2024.109957
4. [4]
  Zhi-Yuan Yue , Hua-Kai Li , Na Wang , Shan-Shan Liu , Le-Ping Miao , Heng-Yun Ye , Chao Shi . Dehydration-triggered structural phase transition-associated ferroelectricity in a hybrid perovskite-type crystal. Chinese Chemical Letters, 2024, 35(10): 109355-. doi: 10.1016/j.cclet.2023.109355
5. [5]
  Jiahao Liu , Peng Liu , Junhong Duan , Qiongxuan Xie , Jie Feng , Hongpei Tan , Ze Mi , Ying Li , Yunjie Liao , Pengfei Rong , Wenhu Zhou , Xiang Gao . Macrophages-mediated tumor accumulation and deep penetration of bismuth/manganese biomineralized nanoparticles for enhanced radiotherapy. Chinese Chemical Letters, 2024, 35(12): 109632-. doi: 10.1016/j.cclet.2024.109632
6. [6]
  Ji Liu , Dongsheng He , Tianjiao Hao , Yumin Hu , Yan Zhao , Zhen Li , Chang Liu , Daquan Chen , Qiyue Wang , Xiaofei Xin , Yan Shen . Gold mineralized "hybrid nanozyme bomb" for NIR-II triggered tumor effective permeation and cocktail therapy. Chinese Chemical Letters, 2024, 35(9): 109296-. doi: 10.1016/j.cclet.2023.109296
7. [7]
  Huan Hu , Ying Zhang , Shi-Shuang Huang , Zhi-Gang Li , Yungui Liu , Rui Feng , Wei Li . Temperature- and pressure-responsive photoluminescence in a 1D hybrid lead halide. Chinese Journal of Structural Chemistry, 2024, 43(10): 100395-100395. doi: 10.1016/j.cjsc.2024.100395
8. [8]
  Chuyu Huang , Zhishan Liu , Linping Zhao , Zuxiao Chen , Rongrong Zheng , Xiaona Rao , Yuxuan Wei , Xin Chen , Shiying Li . Metal-coordinated oxidative stress amplifier to suppress tumor growth combined with M2 macrophage elimination. Chinese Chemical Letters, 2024, 35(12): 109696-. doi: 10.1016/j.cclet.2024.109696
9. [9]
  Ying Gao , Rong Zhou , Qiwen Wang , Shaolong Qi , Yuanyuan Lv , Shuang Liu , Jie Shen , Guocan Yu . Natural killer cell membrane doped supramolecular nanoplatform with immuno-modulatory functions for immuno-enhanced tumor phototherapy. Chinese Chemical Letters, 2024, 35(10): 109521-. doi: 10.1016/j.cclet.2024.109521
10. [10]
  Yuanzheng Wang , Chen Zhang , Shuyan Han , Xiaoli Kong , Changyun Quan , Jun Wu , Wei Zhang . Cancer cell membrane camouflaged biomimetic gelatin-based nanogel for tumor inhibition. Chinese Chemical Letters, 2024, 35(11): 109578-. doi: 10.1016/j.cclet.2024.109578
11. [11]
  Yanfei Liu , Yaqin Hu , Yifu Tan , Qiwen Chen , Zhenbao Liu . Tumor acidic microenvironment activatable DNA nanostructure for precise cancer cell targeting and inhibition. Chinese Chemical Letters, 2025, 36(1): 110289-. doi: 10.1016/j.cclet.2024.110289
12. [12]
  Xiongbo Song , Jinwen Xiao , Juan Wu , Li Sun , Long Chen . Decellularized amniotic membrane promotes the anti-inflammatory response of macrophages via PI3K/AKT/HIF-1α pathway. Chinese Chemical Letters, 2025, 36(1): 109844-. doi: 10.1016/j.cclet.2024.109844
13. [13]
  Wenhao Wang , Siyuan Peng , Zhengwei Huang , Xin Pan . Tuning amino/hydroxyl ratios of nanovesicles to manipulate protein corona-mediated in vivo fate. Chinese Chemical Letters, 2024, 35(11): 110134-. doi: 10.1016/j.cclet.2024.110134
14. [14]
  Ting Pan , Dinghu Zhang , Guomei You , Xiaoxia Wu , Chenguang Zhang , Xinyu Miao , Wenzhi Ren , Yiwei He , Lulu He , Yuanchuan Gong , Jie Lin , Aiguo Wu , Guoliang Shao . PD-L1 targeted iron oxide SERS bioprobe for accurately detecting circulating tumor cells and delineating tumor boundary. Chinese Chemical Letters, 2025, 36(1): 109857-. doi: 10.1016/j.cclet.2024.109857
15. [15]
  An Lu , Yuhao Guo , Yi Yan , Lin Zhai , Xiangyu Wang , Weiran Cao , Zijie Li , Zhixia Zhao , Yujie Shi , Yuanjun Zhu , Xiaoyan Liu , Huining He , Zhiyu Wang , Jian-Cheng Wang . Nanomedicine integrating the lipidic derivative of 5-fluorouracil, miriplatin and PD-L1 siRNA for enhancing tumor therapy. Chinese Chemical Letters, 2024, 35(6): 108928-. doi: 10.1016/j.cclet.2023.108928
16. [16]
  Yuanyuan Zeng , Fang Liu , Jun Wang , Bianfei Shao , Tao He , Zhongzheng Xiang , Yan Wang , Shunyao Zhu , Tian Yang , Siting Yu , Changyang Gong , Lei Liu . Fisetin micelles precisely exhibit a radiosensitization effect by inhibiting PDGFRβ/STAT1/STAT3/Bcl-2 signaling pathway in tumor. Chinese Chemical Letters, 2025, 36(2): 109734-. doi: 10.1016/j.cclet.2024.109734
17. [17]
  Zhanhui Yang , Jiaxi Xu . (m+n+…) or [m+n+…]cycloaddition?. University Chemistry, 2025, 40(3): 387-389. doi: 10.12461/PKU.DXHX202406032
18. [18]
  Haiyang Gu , Xiang Xu . Multicolor hybrid metal halides and anti-counterfeiting. Chinese Journal of Structural Chemistry, 2024, 43(9): 100352-100352. doi: 10.1016/j.cjsc.2024.100352
19. [19]
  Xing Tian , Di Wu , Wanheng Wei , Guifu Dai , Zhanxian Li , Benhua Wang , Mingming Yu . A lipid droplets-targetable fluorescent probe for polarity detection in cells of iron death, inflammation and fatty liver tissue. Chinese Chemical Letters, 2024, 35(6): 108912-. doi: 10.1016/j.cclet.2023.108912
20. [20]
  Ning LI , Siyu DU , Xueyi WANG , Hui YANG , Tao ZHOU , Zhimin GUAN , Peng FEI , Hongfang MA , Shang JIANG . Preparation and efficient catalysis for olefins epoxidation of a polyoxovanadate-based hybrid. Chinese Journal of Inorganic Chemistry, 2024, 40(4): 799-808. doi: 10.11862/CJIC.20230372

Get Citation

PDF

XML

Metrics

PDF Downloads(1)
Abstract views(76)
HTML views(8)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142